X-25013317-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000379044.5(ARX):āc.678C>Gā(p.Asp226Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000906 in 110,399 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Synonymous variant affecting the same amino acid position (i.e. D226D) has been classified as Likely benign.
Frequency
Consequence
ENST00000379044.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARX | NM_139058.3 | c.678C>G | p.Asp226Glu | missense_variant | 2/5 | ENST00000379044.5 | NP_620689.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARX | ENST00000379044.5 | c.678C>G | p.Asp226Glu | missense_variant | 2/5 | 1 | NM_139058.3 | ENSP00000368332 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000906 AC: 1AN: 110364Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 32722
GnomAD3 exomes AF: 0.0000103 AC: 1AN: 97042Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 34988
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000288 AC: 3AN: 1041776Hom.: 0 Cov.: 32 AF XY: 0.00000587 AC XY: 2AN XY: 340748
GnomAD4 genome AF: 0.00000906 AC: 1AN: 110399Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 32767
ClinVar
Submissions by phenotype
Intellectual disability, X-linked, with or without seizures, arx-related;C3463992:Developmental and epileptic encephalopathy, 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 30, 2022 | This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 226 of the ARX protein (p.Asp226Glu). This variant is present in population databases (rs764730866, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with ARX-related conditions. ClinVar contains an entry for this variant (Variation ID: 1057299). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ARX protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at